BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11678935)

  • 1. Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy.
    Pantosti A; D'Ambrosio F; Bordi E; Scotto D'Abusco A; Del Grosso M
    Clin Microbiol Infect; 2001 Sep; 7(9):503-6. PubMed ID: 11678935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.
    Reinert RR; Kresken M; Mechery V; Lemperle M; Lütticken R
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):662-5. PubMed ID: 9832271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients.
    Obert CA; Miller ML; Montgomery J; Adamkiewicz T; Tuomanen EI
    Antimicrob Agents Chemother; 2007 Jan; 51(1):386-9. PubMed ID: 17060526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest.
    Biedenbach D; Wanger A; Jones RN
    J Antimicrob Chemother; 1996 Sep; 38(3):553-5. PubMed ID: 8889731
    [No Abstract]   [Full Text] [Related]  

  • 5. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 1998 Apr; 42(4):945-6. PubMed ID: 9559816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
    Lozniewski A; Lion C; Mory F; Weber M
    Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of linezolid, quinupristin-dalfopristin and newer quinolones against Streptococcus pneumoniae.
    Abb J
    Int J Antimicrob Agents; 2003 Mar; 21(3):289-91. PubMed ID: 12636994
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.
    Morosini MI; Cantón R; Loza E; Negri MC; Galán JC; Almaraz F; Baquero F
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2427-31. PubMed ID: 11502509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
    Calatayud L; Ardanuy C; Cercenado E; Fenoll A; Bouza E; Pallares R; Martín R; Liñares J
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3240-6. PubMed ID: 17606677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.
    Betriu C; Redondo M; Palau ML; Sánchez A; Gómez M; Culebras E; Boloix A; Picazo JJ
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1838-41. PubMed ID: 10858339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis.
    Tarasi A; Dever LL; Tomasz A
    J Antimicrob Chemother; 1997 May; 39 Suppl A():121-7. PubMed ID: 9511076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
    Sader HS; Jones RN; Ballow CH; Biedenbach DJ; Cered RF;
    Braz J Infect Dis; 2001 Feb; 5(1):21-31. PubMed ID: 11290311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
    Pankuch GA; Lichtenberger C; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1653-6. PubMed ID: 8807057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid.
    Rodriguez-Avial I; Rodriguez-Avial C; Culebras E; Picazo JJ
    Int J Antimicrob Agents; 2003 Jun; 21(6):536-41. PubMed ID: 12791466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey.
    Sener B; Köseoglu O; Gür D; Bryskier A
    J Chemother; 2005 Feb; 17(1):31-5. PubMed ID: 15828441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.
    Jones RN; Ballow CH; Biedenbach DJ; Deinhart JA; Schentag JJ
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):437-51. PubMed ID: 9635235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of antiribosomal agents on penicillin-susceptible and -resistant Streptococcus pneumoniae in relation to their resistance genotypes.
    Sener B; Köseoglu O
    Int J Antimicrob Agents; 2004 Jul; 24(1):39-42. PubMed ID: 15225859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.
    Novotná G; Spízek J; Janata J
    Folia Microbiol (Praha); 2007; 52(6):593-9. PubMed ID: 18450221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.